Experimental data are limited regarding the status of leptin during the progression of ALS, even though this hormone is historically known for its important role in regulating body weight, and mild obesity appears to improve survival in ALS patients [28]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.